Verition Fund Management
MED icon

Verition Fund Management’s Medifast MED Stock Holding History

Verition Fund Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,842
Closed -$265K – 3056
2025
Q4 		$265K Buy
24,842
+3,306
+15% +$39.6K ﹤0.01% 3067
2025
Q3 		$294K Buy
+21,536
New +$301K ﹤0.01% 3303
2024
Q3 		– Sell
-38,773
Closed -$846K – 3400
2024
Q2 		$846K Buy
+38,773
New +$1.03M ﹤0.01% 1777
2022
Q3 		– Sell
-1,264
Closed -$228K – 3158
2022
Q2 		$228K Buy
+1,264
New +$226K ﹤0.01% 1871
2020
Q1 		– Sell
-15,504
Closed -$1.7M – 874
2019
Q4 		$1.7M Buy
+15,504
New +$1.5M 0.03% 302
2019
Q2 		– Sell
-2,400
Closed -$306K – 1250
2019
Q1 		$306K Buy
+2,400
New +$304K 0.01% 827
2018
Q4 		– Sell
-5,363
Closed -$1.19M – 1089
2018
Q3 		$1.19M Buy
5,363
+3,317
+162% +$672K 0.04% 499
2018
Q2 		$328K Buy
+2,046
New +$262K 0.02% 824

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Verition Fund Management's MED Position: Q1 2026 in Review

Verition Fund Management sold out of Medifast (MED) in Q1 2026, closing a stake of 24,842 shares — an estimated $265K sold.

Verition Fund Management first reported a position in MED in Q2 2018 and held it in 8 quarters. The position peaked at $1.7M in Q4 2019. 112 funds tracked by Wall St. Rank hold MED as of Q1 2026.

  • Verition Fund Management reported no remaining Medifast position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 24,842 Medifast shares in Q1 2026, an estimated $265K.
  • Verition Fund Management first reported a position in Medifast in Q2 2018 and held it in 8 quarters.
  • Verition Fund Management's Medifast position peaked at $1.7M in Q4 2019.
  • 112 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.